Oncology and molecular diagnostics professional with leadership in reimbursement, CLIA laboratory commercialization, and clinical evidence development of novel molecular diagnostics. Extensive background in clinical research and strong publication history in medical oncology and genetics.
Sysmex Inostics is a molecular diagnostic company whose core competency is mutation detection utilizing highly sensitive technologies such as Plasma-Sequencing and BEAMing. With BEAMing being one of the most sensitive and quantitative technologies available today for the detection of tumor specific somatic mutations in blood samples
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
